Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Amortizatization of Intangibles (2018 - 2026)

Vericel (VCEL) posted Amortizatization of Intangibles of $52000.0 for Q2 2026, up 92.59% sequentially from $27000.0 in Q1 2026, and down 1.89% YoY from $53000.0 in Q2 2025.

Analysis

Vericel (VCEL) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends

Vericel has reported Amortizatization of Intangibles for 9 years, with the latest figure at $52000.0 in Q2 2026.

  • Quarterly Amortizatization of Intangibles fell 1.89% year-over-year to $52000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $90000.0 (down 80.6% YoY) and the FY2025 annual result came in at $183000.0, down 72.15% from the prior year.
  • Amortizatization of Intangibles improved to $52000.0 in Q2 2026 per VCEL's latest filing, from $27000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $290000.0 in Q1 2023 and troughed at -$194000.0 in Q1 2022.
  • A 5-year average of $90888.9 and a median of $86000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles soared 9566.67% in 2023, then plunged 151.3% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $198000.0 in 2022, then slumped by 81.82% to $36000.0 in 2023, then surged by 219.44% to $115000.0 in 2024, then slumped by 151.3% to -$59000.0 in 2025, then jumped by 188.14% to $52000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $52000.0, $27000.0, and -$59000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 1.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.40 Mn
Mar 31, 2026 1.37 Mn
Dec 31, 2025 1.34 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 1.51 Mn
Sep 30, 2024 1.66 Mn
Jun 30, 2024 1.71 Mn
Mar 31, 2024 1.77 Mn
Dec 31, 2023 1.78 Mn
Sep 30, 2023 1.83 Mn
Jun 30, 2023 1.35 Mn
Mar 31, 2023 1.11 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 965,000.00
Jun 30, 2022 1.08 Mn
Mar 31, 2022 1.08 Mn
Dec 31, 2021 1.00 Mn
Sep 30, 2021 1.10 Mn